Simulations Plus, Inc. (NASDAQ:SLP) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 3.7% in the 3rd quarter, HoldingsChannel reports. The firm owned 45,416 shares of the technology company’s stock after selling 1,768 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Simulations Plus were worth $1,454,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the stock. Azzad Asset Management Inc. ADV raised its holdings in Simulations Plus by 3.6% in the 2nd quarter. Azzad Asset Management Inc. ADV now owns 8,007 shares of the technology company’s stock valued at $389,000 after acquiring an additional 280 shares during the last quarter. First Horizon Advisors Inc. raised its holdings in Simulations Plus by 82.6% in the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock valued at $26,000 after acquiring an additional 370 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in Simulations Plus by 7.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,391 shares of the technology company’s stock valued at $311,000 after acquiring an additional 456 shares during the last quarter. Pitcairn Co. raised its holdings in Simulations Plus by 9.1% in the 3rd quarter. Pitcairn Co. now owns 6,599 shares of the technology company’s stock valued at $211,000 after acquiring an additional 549 shares during the last quarter. Finally, Tributary Capital Management LLC raised its holdings in Simulations Plus by 0.4% in the 2nd quarter. Tributary Capital Management LLC now owns 210,445 shares of the technology company’s stock valued at $10,232,000 after acquiring an additional 768 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on SLP shares. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, November 6th. BTIG Research lowered their price objective on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. StockNews.com cut shares of Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. Finally, Stephens started coverage on shares of Simulations Plus in a research note on Friday, November 15th. They set an “overweight” rating and a $39.00 price objective for the company. One analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $51.40.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $27.66, for a total value of $553,200.00. Following the sale, the director now owns 3,462,584 shares of the company’s stock, valued at $95,775,073.44. The trade was a 0.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In the last 90 days, insiders sold 60,750 shares of company stock valued at $1,837,255. Insiders own 20.90% of the company’s stock.

Simulations Plus Stock Performance

Shares of NASDAQ:SLP opened at $30.88 on Tuesday. The firm has a 50 day simple moving average of $30.80 and a 200 day simple moving average of $36.24. Simulations Plus, Inc. has a 52 week low of $27.07 and a 52 week high of $51.22. The company has a market cap of $619.67 million, a PE ratio of 63.02 and a beta of 0.76.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. The company had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company’s revenue for the quarter was up 19.9% on a year-over-year basis. During the same quarter last year, the business posted $0.18 EPS. On average, equities analysts predict that Simulations Plus, Inc. will post 1.1 earnings per share for the current year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.